59 results
8-K
EX-10.2
URGN
UroGen Pharma Ltd.
8 Aug 24
Departure of Directors or Certain Officers
4:30pm
) progress of internal research or development programs; (xlvii) acquisition of new customers; (xlviii) customer retention and/or repeat order rate; (xlix
8-K
EX-1.1
URGN
UroGen Pharma Ltd.
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
principal supplier, manufacturer, customer or contractor of the Company, exists or, to the knowledge of the Company, is threatened or imminent, which
424B5
URGN
UroGen Pharma Ltd.
18 Jun 24
Prospectus supplement for primary offering
5:05pm
because they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold securities in street name
424B5
uwpi29wezmizxtz9p
17 Jun 24
Prospectus supplement for primary offering
4:19pm
8-K
EX-10.1
d13x9 6w4u3k6
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am